Cost-effectiveness model to evaluate 200-days vs 100-days treatment with valganciclovir prophylaxis to reduce cytomegalovirus disease in high-risk (D+/R-) kidney transplant recipient in Spain
![Thumbnail](/xmlui/themes/Mirage2//images/thumbnails/thumn_cientif.png)
Fecha de publicación
2011Título de revista
TRANSPLANT INTERNATIONAL
Tipo de contenido
Publicación de congreso
![](/xmlui/themes/Mirage2//images/final_lines.png)